Loss-of-function Mutations in CST6 Cause Dry Skin, Desquamation and Abnormal Keratosis without Hypotrichosis

Cystatin M/E (encoded by the CST6 gene) is a cysteine protease inhibitor, that exerts regulatory and protective effects against uncontrolled proteolysis mainly by directly regulating Cathepsin V, Cathepsin L, and Legumain activities. Previous studies have suggested that CST6 may exert a regulatory role in epidermal differentiation and hair follicle formation by inhibiting the activity of respective cognate target proteases. However, until recently, studies have revealed that loss- or gain-of-function of the CST6 gene causes dry skin with hypotrichosis in humans. Here we reported two siblings of Chinese origin with dry skin, desquamation and abnormal keratosis without hypotrichosis. By applying whole-exome sequencing, we identified homozygous loss-of-function mutation c.251G>A (p.Gly84Asp) in the CST6 gene as the underlying genetic cause. Further fluorimetric Enzyme assays demonstrated the mutant Cystatin M/E protein lost its inhibitory function on the protease activity of cathepsins. Moreover, the corresponding mutation in mice resulted in excessive cornification, desquamation, impaired skin barrier function, and abnormal proliferation and differentiation of keratinocytes. In conclusion, the homozygous missense mutation c.251G>A in CST6 gene resulted in dry skin, desquamation, as well as abnormal keratosis of the skin, promoting our understanding of the role of protease-antiprotease balance in human skin disorders. This article is protected by copyright. All rights reserved.

CST6; abnormal keratosis; cystatin M/E; desquamation; dry skin; mouse model; protease inhibitor.